Calcitriol inhibits hedgehog signaling and induces vitamin D receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Uhmann, Anja ^a   Niemann, Hannah ^a   Lammering, Bérénice ^a   Henkel, Cornelia ^a   Heß, Ina ^a   Rosenberger, Albert ^a   Dullin, Christian ^a   Schraepler, Anke ^a   Schulz Schaeffer, Walter ^a   Hahn, Heidi ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM BLOOD LEVEL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT DURATION; TUMOR DIFFERENTIATION; TUMOR VOLUME; VITAMIN SUPPLEMENTATION;

EID: 84858113256     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/357040     Document Type: Article

References (38)

1. Hooper J. E., Scott M. P., Communicating with hedgehogs Nature Reviews Molecular Cell Biology 2005 6 4 306 317 (Pubitemid 40516897)
2. Yang L., Xie G., Fan Q., Xie J., Activation of the hedgehog-signaling pathway in human cancer and the clinical implications Oncogene 2010 29 4 469 481
3. Merlino G., Helman L. J., Rhabdomyosarcomaworking out the pathways Oncogene 1999 18 38 5340 5348
4. Barr F. G., Qualman S. J., Macris M. H., Melnyk N., Lawlor E. R., Strzelecki D. M., Triche T. J., Bridge J. A., Sorensen P. H. B., Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions Cancer Research 2002 62 16 4704 4710
5. Sorensen P. H. B., Lynch J. C., Qualman S. J., Tirabosco R., Lim J. F., Maurer H. M., Bridge J. A., Crist W. M., Tricke T. J., Barr F. G., PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group Journal of Clinical Oncology 2002 20 11 2672 2679 (Pubitemid 34575640)
6. Dagher R., Helman L., Rhabdomyosarcoma: an overview Oncologist 1999 4 1 34 44 (Pubitemid 29102453)
7. Ognjanovic S., Linabery A. M., Charbonneau B., Ross J. A., Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 19752005 Cancer 2009 115 18 4218 4226
8. De Giovanni C., Landuzzi L., Nicoletti G., Lollini P. L., Nanni P., Molecular and cellular biology of rhabdomyosarcoma Future Oncology 2009 5 9 1449 1475
9. Breneman J. C., Lyden E., Pappo A. S., Link M. P., Anderson J. R., Parham D. M., Qualman S. J., Wharam M. D., Donaldson S. S., Maurer H. M., Meyer W. H., Baker K. S., Paidas C. N., Crist W. M., Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcomaa report from the Intergroup Rhabdomyosarcoma Study IV Journal of Clinical Oncology 2003 21 1 78 84
10. Zibat A., Missiaglia E., Rosenberger A., Pritchard-Jones K., Shipley J., Hahn H., Fulda S., Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma Oncogene 2010 29 48 6323 6330
11. Pressey J. G., Anderson J. R., Crossman D. K., Lynch J. C., Barr F. G., Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group Pediatric Blood and Cancer 2011 57 6 930 938
12. Hahn H., Wojnowski L., Zimmer A. M., Hall J., Miller G., Zimmer A., Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome Nature Medicine 1998 4 5 619 622 (Pubitemid 28237364)
13. Kappler R., Bauer R., Calzada-Wack J., Rosemann M., Hemmerlein B., Hahn H., Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma Oncogene 2004 23 54 8785 8795 (Pubitemid 39593293)
14. Nitzki F., Zibat A., Frommhold A., Schneider A., Schulz-Schaeffer W., Braun T., Hahn H., Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice Oncogene 2011 30 43 4428 4436
15. Ecke I., Rosenberger A., Obenauer S., Dullin C., Aberger F., Kimmina S., Schweyer S., Hahn H., Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth Molecular Carcinogenesis 2008 47 5 361 372 (Pubitemid 351614576)
16. Deeb K. K., Trump D. L., Johnson C. S., Vitamin D signalling pathways in cancer: potential for anticancer therapeutics Nature Reviews Cancer 2007 7 9 684 700 (Pubitemid 47327412)
17. Shabahang M., Buffan A. E., Nolla J. M., Schumaker L. M., Brenner R. V., Buras R. R., Nauta R. J., Evans S. R. T., The effect of 1,25-dihydroxyvitamin D 3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor Annals of Surgical Oncology 1996 3 2 144 149 (Pubitemid 126729502)
18. Uhmann A., Niemann H., Lammering B., Henkel C., He I., Nitzki F., Fritsch A., Prfer N., Rosenberger A., Dullin C., Schraepler A., Reifenberger J., Schweyer S., Pietsch T., Strutz F., Schulz-Schaeffer W., Hahn H., Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation Molecular Cancer Therapeutics 2011 10 11 2179 2188
19. Bijlsma M. F., Spek C. A., Zivkovic D., van de Water S., Rezaee F., Peppelenbosch M. P., Repression of smoothened by patched-dependent (pro-)vitamin D 3 secretion PLoS Biology 2006 4 8, article e232
20. Chen J. K., Taipale J., Young K. E., Maiti T., Beachy P. A., Small molecule modulation of smoothened activity Proceedings of the National Academy of Sciences of the United States of America 2002 99 22 14071 14076 (Pubitemid 35257626)
21. Talpale J., Chen J. K., Cooper M. K., Wang B., Mann R. K., Milenkovic L., Scott M. P., Beachy P. A., Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine Nature 2000 406 6799 1005 1009
22. Hahn H., Nitzki F., Schorban T., Hemmerlein B., Threadgill D., Rosemann M., Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2 Genomics 2004 84 5 853 858 (Pubitemid 39314445)
23. Calzada-Wack J., Kappler R., Schnitzbauer U., Richter T., Nathrath M., Rosemann M., Wagner S. N., Hein R., Hahn H., Unbalanced overexpression of the mutant allele in murine Patched mutants Carcinogenesis 2002 23 5 727 733 (Pubitemid 34567510)
24. Zibat A., Uhmann A., Nitzki F., Wijgerde M., Frommhold A., Heller T., Armstrong V., Wojnowski L., Quintanilla-Martinez L., Reifenberger J., Schulz-Schaeffer W., Hahn H., Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts Carcinogenesis 2009 30 6 918 926
25. Banach-Petrosky W., Ouyang X., Gao H., Nader K., Ji Y., Suh N., DiPaola R. S., Abate-Shen C., Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1; Pten mutant mice Clinical Cancer Research 2006 12 19 5895 5901 (Pubitemid 44629623)
26. Greschus S., Kiessling F., Lichy M. P., Moll J., Mueller M. M., Savai R., Rose F., Ruppert C., Gnther A., Luecke M., Fusenig N. E., Semmler W., Traupe H., Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging Neoplasia 2005 7 8 730 740
27. Nitzki F., Zibat A., Knig S., Wijgerde M., Rosenberger A., Brembeck F. H., Carstens P. O., Frommhold A., Uhmann A., Klingler S., Reifenberger J., Pukrop T., Aberger F., Schulz-Schaeffer W., Hahn H., Tumor stroma-derived Wnt5a induces differentiation of basal cell carcinoma of ptch-mutant mice via caMKII Cancer Research 2010 70 7 2739 2748
28. Chargé S. B. P., Rudnicki M. A., Cellular and molecular regulation of muscle regeneration Physiological Reviews 2004 84 1 209 238 (Pubitemid 38049880)
29. De la Serna I. L., Carlson K. A., Imbalzano A. N., Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation Nature Genetics 2001 27 2 187 190 (Pubitemid 32157446)
30. Tostar U., Toftgrd R., Zaphiropoulos P. G., Shimokawa T., Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway Genes and Cancer 2010 1 9 941 951
31. Gerber A. N., Wilson C. W., Li Y. J., Chuang P. T., The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation Oncogene 2007 26 8 1122 1136
32. Sirri V., Leibovitch M. P., Leibovitch S. A., Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain Oncogene 2003 22 36 5658 5666 (Pubitemid 37102702)
33. Cabane C., Englaro W., Yeow K., Ragno M., Dérijard B., Regulation of C2C12 myogenic terminal differentiation by MKK3/p38 -pathway American Journal of Physiology 2003 284 3 C658 C666
34. Selles J., Massheimer V., Santillan G., Marinissen M. J., Boland R., Effects of calcitriol and its analogues, calcipotriol (MC 903) and 20- epi-1,25-dihydroxyvitamin D 3 (MC 1288), on calcium influx and DNA synthesis in cultured muscle cells Biochemical Pharmacology 1997 53 12 1807 1814 (Pubitemid 27356053)
35. Drittanti L., De Boland A. R., Boland R., Modulation of DNA synthesis in cultured muscle cells by 1,25-dihydroxyvitamin D 3 Biochimica et Biophysica Acta 1989 1014 2 112 119 (Pubitemid 19283086)
36. Drittanti L. N., Boland R. L., De Boland A. R., Induction of specific proteins in cultured skeletal muscle cells by 1,25-dihydroxyvitamin D 3 Biochimica et Biophysica Acta 1989 1012 1 16 23 (Pubitemid 19154914)
37. Zella L. A., Kim S., Shevde N. K., Pike J. W., Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D 3 Molecular Endocrinology 2006 20 6 1231 1247 (Pubitemid 43801228)
38. Weber W. A., Assessing tumor response to therapy Journal of Nuclear Medicine 2009 50 supplement 1 1S 10S